MARLBOROUGH, Mass.,
May 17, 2017 /PRNewswire/
-- Boston Scientific Corporation (NYSE: BSX) is scheduled to
participate in the 2017 UBS Global Healthcare Conference on
Tuesday, May 23, 2017 in New York City.
Susie Lisa, vice president,
investor relations and Lindsay Fish,
senior manager, investor relations, will participate in a 30-minute
question-and-answer-session with the host analyst beginning at
approximately 2:00 p.m. A live
webcast of the session will be available on the Investor Relations
section of the Boston Scientific website at
www.bostonscientific.com/investors. We encourage interested parties
to register at least 15 minutes prior to the scheduled start time
to ensure a timely connection. A replay of the webcast will be
accessible at www.bostonscientific.com/investors beginning
approximately one hour following the completion of the event.
About Boston Scientific
Boston Scientific transforms
lives through innovative medical solutions that improve the health
of patients around the world. As a global medical technology
leader for more than 35 years, we advance science for life by
providing a broad range of high performance solutions that address
unmet patient needs and reduce the cost of healthcare. For more
information, visit www.bostonscientific.com and connect on Twitter
and Facebook.
CONTACTS
|
|
Media:
|
Investors:
|
Emily
Anderson
|
Susie Lisa,
CFA
|
508-683-6305
(office)
|
508- 683-5565
(office)
|
Media
Relations
|
Investor
Relations
|
Boston Scientific
Corporation
|
Boston Scientific
Corporation
|
emily.anderson2@bsci.com
|
investor_relations@bsci.com
|
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/boston-scientific-to-participate-in-2017-ubs-global-healthcare-conference-300459211.html
SOURCE Boston Scientific Corporation